(Q36704163)

15 August 2017

1 reference

title

New approaches to the treatment of follicular lymphoma (English)

1 reference

15 August 2017

A. Z. Rohatiner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721524

8 November 2022

T. A. Lister

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1721524

8 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

full work available at URL

15 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1991.tb08039.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1991.tb08039.x/fullpdf

8 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

British Journal of Haematology

8 November 2022

published in

1 reference

15 August 2017

79

1 reference

15 August 2017

349-354

1 reference

15 August 2017

3

1 reference

Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Histological transformation of non-hodgkin's lymphoma.A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Recurrence Rates Following Radiation Therapy of Nodular and Diffuse Malignant Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Increased survival in mice inoculated with tumor cells and treated with interferon preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the American Cancer Society trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Remission induction and remission duration with primary radiotherapy in advanced lymphosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

The management of follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Non-hodgkin's lymphoma.A study of the evolution of the disease based upon 92 autopsied cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Chlorambucil and interferon for low grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Total body irradiation in advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Antibody to a molecularly-defined antigen confined to a tumour cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Follicular lymphoma: a model of lymphoid tumor progression in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1991.TB08039.X

Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

8 November 2022

Cancer Treatment Reports

2

70

871

Armitage J. O.

1986

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Advanced Lymphosarcoma: Intensive Cyclical Combination Chemotherapy with Cyclophosphamide, Vincristine, and Prednisone

8 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma

8 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

8 November 2022

Cancer Treatment Reports

9

61

1149

Chaffey J. T.

1977

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Brief communication: Cure of murine leukemia with drug and interferon treatment.

8 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas

8 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas

8 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression

8 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Moderate versus aggressive chemotherapy of nodular lymphocytic poorly differentiated lymphoma

8 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

The American Journal of Pathology

8 November 2022

24

18

281

Gall E. A.

1942

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Follicular lymphoma: prognostic factors for response and survival

8 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Follicular non-Hodgkin's lymphoma

8 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody

8 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience

8 November 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma

8 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Individual antigenic specificity of immunoglobulins

8 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Clinical evaluation of CB 1348 in malignant lymphoma and related diseases

8 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Combination versus successive single agent chemotherapy in lymphocytic lymphoma

8 November 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease

8 November 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type

8 November 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma

8 November 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

8 November 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody

8 November 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma

8 November 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study

8 November 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II

8 November 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

8 November 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

8 November 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma

8 November 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Annals of Internal Medicine

8 November 2022

64

112

10

Portlock C. S.

1990

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

8 November 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Journal of Clinical Oncology

8 November 2022

68

author name string

Price C. G. A.

publication date

1991

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Alpha interferon for induction of remission in hairy-cell leukemia

8 November 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study

8 November 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Clinical and laboratory investigations on man: systemic administration of potent interferon to man.

8 November 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

8 November 2022

Archives of pathology

84

26

603

Symmers D.

1938

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

8 November 2022

85

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma

8 November 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

British Journal of Cancer

8 November 2022

87

author name string

Whelan J.

publication date

1991

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1991.TB08039.X

8 November 2022

Identifiers

1 reference

15 August 2017

1 reference